| Sanaa Saher Mithaiwala, DO | |
|
175 Madison Ave Fl 1, Mount Holly, NJ 08060-2038 | |
| (609) 914-6000 | |
| Not Available |
| Full Name | Sanaa Saher Mithaiwala |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 15 Years |
| Location | 175 Madison Ave Fl 1, Mount Holly, New Jersey |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1922234004 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | 25MB09219200 (New Jersey) | Secondary |
| 207R00000X | Internal Medicine | 25MB09219200 (New Jersey) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Virtua Memorial Hospital Of Burlington County | Mount holly, NJ | Hospital |
| Virtua West Jersey Hospitals | Voorhees, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Virtua Medical Group, Pa | 9830222397 | 1226 |
News Archive
Biovail Corporation today provided an update on its Phase III program with pimavanserin for Parkinson's disease psychosis (PDP), which is being pursued in collaboration with ACADIA Pharmaceuticals Inc. Following the announcement on September 1st of disappointing top-line results from the first Phase III PDP trial, Biovail and ACADIA remain committed to the successful development of pimavanserin and have established a development strategy that they believe will strengthen the PDP program.
A new study by research chemists at the University of Warwick has challenged a century old rule of pharmacology that defined how quickly key chemicals can pass across cell walls. The new observations of the Warwick researchers suggest that the real transport rates could be up to a hundred times slower than predicted by the century old "Overton's Rule". This could have major implications for the development and testing of many future drugs.
Watson Pharmaceuticals, Inc. today announced a definitive agreement to acquire a portfolio of generic pharmaceutical products that are being divested as a result of the merger between Perrigo Company and Paddock Laboratories.
The cases coming before the court "address some of the central issues facing the country," said former Solicitor General Walter Dellinger. The clashes over health care and immigration "are not mere lawyers' issues, but fundamental questions about how the country is governed."
Whether fruit, meat or cheese - the quality of food is not always as consumers would like it to be. But, in future, a spectrometer will allow them to gage the quality of food before they buy it. No bigger than a sugar cube, the device is inexpensive to manufacture and could one day even be installed in smartphones.
› Verified 4 days ago
| Entity Name | Virtua Medical Group, Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649226515 PECOS PAC ID: 9830222397 Enrollment ID: O20100804000338 |
News Archive
Biovail Corporation today provided an update on its Phase III program with pimavanserin for Parkinson's disease psychosis (PDP), which is being pursued in collaboration with ACADIA Pharmaceuticals Inc. Following the announcement on September 1st of disappointing top-line results from the first Phase III PDP trial, Biovail and ACADIA remain committed to the successful development of pimavanserin and have established a development strategy that they believe will strengthen the PDP program.
A new study by research chemists at the University of Warwick has challenged a century old rule of pharmacology that defined how quickly key chemicals can pass across cell walls. The new observations of the Warwick researchers suggest that the real transport rates could be up to a hundred times slower than predicted by the century old "Overton's Rule". This could have major implications for the development and testing of many future drugs.
Watson Pharmaceuticals, Inc. today announced a definitive agreement to acquire a portfolio of generic pharmaceutical products that are being divested as a result of the merger between Perrigo Company and Paddock Laboratories.
The cases coming before the court "address some of the central issues facing the country," said former Solicitor General Walter Dellinger. The clashes over health care and immigration "are not mere lawyers' issues, but fundamental questions about how the country is governed."
Whether fruit, meat or cheese - the quality of food is not always as consumers would like it to be. But, in future, a spectrometer will allow them to gage the quality of food before they buy it. No bigger than a sugar cube, the device is inexpensive to manufacture and could one day even be installed in smartphones.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Sanaa Saher Mithaiwala, DO 301 Lippincott Dr Ste 410, Marlton, NJ 08053-4197 Ph: (856) 355-0340 | Sanaa Saher Mithaiwala, DO 175 Madison Ave Fl 1, Mount Holly, NJ 08060-2038 Ph: (609) 914-6000 |
News Archive
Biovail Corporation today provided an update on its Phase III program with pimavanserin for Parkinson's disease psychosis (PDP), which is being pursued in collaboration with ACADIA Pharmaceuticals Inc. Following the announcement on September 1st of disappointing top-line results from the first Phase III PDP trial, Biovail and ACADIA remain committed to the successful development of pimavanserin and have established a development strategy that they believe will strengthen the PDP program.
A new study by research chemists at the University of Warwick has challenged a century old rule of pharmacology that defined how quickly key chemicals can pass across cell walls. The new observations of the Warwick researchers suggest that the real transport rates could be up to a hundred times slower than predicted by the century old "Overton's Rule". This could have major implications for the development and testing of many future drugs.
Watson Pharmaceuticals, Inc. today announced a definitive agreement to acquire a portfolio of generic pharmaceutical products that are being divested as a result of the merger between Perrigo Company and Paddock Laboratories.
The cases coming before the court "address some of the central issues facing the country," said former Solicitor General Walter Dellinger. The clashes over health care and immigration "are not mere lawyers' issues, but fundamental questions about how the country is governed."
Whether fruit, meat or cheese - the quality of food is not always as consumers would like it to be. But, in future, a spectrometer will allow them to gage the quality of food before they buy it. No bigger than a sugar cube, the device is inexpensive to manufacture and could one day even be installed in smartphones.
› Verified 4 days ago
Sharon Franklin Castellino, Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 175 Madison Ave, Mount Holly, NJ 08060 Phone: 609-914-6180 Fax: 609-914-6182 | |
Jyothi Jagadeesh, M.D Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 175 Madison Ave, Mount Holly, NJ 08060 Phone: 609-914-6180 Fax: 609-914-6182 | |
Amara Nidimusili, Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 175 Madison Ave, Mount Holly, NJ 08060 Phone: 609-914-6000 Fax: 609-914-6182 | |
Dr. Caroline Michelle Ropiak, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 175 Madison Ave, Mount Holly, NJ 08060 Phone: 609-914-6000 | |
Dr. Michael A Lawandy, D.O. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 175 Madison Ave, Mount Holly, NJ 08060 Phone: 609-914-6180 Fax: 609-914-6182 | |
Dr. Sabeeha Nisar, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 175 Madison Ave, Mount Holly, NJ 08060 Phone: 609-914-6180 Fax: 609-914-6182 | |
Shahjahan Nisar Chaudhry, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 175 Madison Ave, Mount Holly, NJ 08060 Phone: 609-914-6000 Fax: 609-914-6182 |